Showing results (51-60 of 215) with videos related to

Sort By:
Pageof 22
Neurosurgery|May 31, 2018
Isocitrate Dehydrogenase Mutations in Low-Grade Gliomas Correlate With Prolonged Overall Survival in Older PatientsPamela S Jones, Kate T Carroll, Matthew Koch, et al.
Journal of Neuro-Oncology|July 23, 2025
Factors associated with cognitive impairment in long-term IDH-mutant glioma survivorsTyler A Lanman, Hana Gross, Caylin M Faria, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|May 8, 2024
CDKN2A/B Homozygous Deletion Sensitizes IDH-Mutant Glioma to CDK4/6 InhibitionAli M Nasser, Lisa Melamed, Ethan A Wetzel, et al.
Neurosurgical Focus|February 1, 2024
Suppression of antitumor immune signatures and upregulation of VEGFA as IDH-mutant gliomas progress to higher gradeEric P Grewal, Leland G K Richardson, Jing Sun, et al.
Neuro-Oncology|July 26, 2020
Sirtuin activation targets IDH-mutant tumorsJulie J Miller, Alexandria Fink, Jack A Banagis, et al.
Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia|June 10, 2016
Impact of histopathological transformation and overall survival in patients with progressive anaplastic gliomaAllen L Ho, Matthew J Koch, Shota Tanaka, et al.
Acta Neuropathologica Communications|May 1, 2019
PIK3CA activating mutations are associated with more disseminated disease at presentation and earlier recurrence in glioblastomaShota Tanaka, Tracy T Batchelor, A John Iafrate, et al.
Seminars in Radiation Oncology|June 7, 2020
Repeat Radiation in the Brain: Managing Patients With Locally Recurrent GliomaDaniel M Trifiletti, Timothy D Malouff, Susan L McGovern, et al.
Journal of Neuro-Oncology|December 12, 2018
Radiographic assessment of contrast enhancement and T2/FLAIR mismatch sign in lower grade gliomas: correlation with molecular groupsTareq A Juratli, Shilpa S Tummala, Angelika Riedl, et al.
Pageof 22